NORSK MEDISINSK SYKLOTRONSENTER AS
Signals
- Driftsunderskudd 2025 Siste driftsresultat er negativt (−372k kr).
NORSK MEDISINSK SYKLOTRONSENTER AS is registered as a limited company in Oslo, Oslo with organisation number 986358692. The business is classified under manufacture of pharmaceutical preparations (NACE 21.200). The company was incorporated in 2003 and has 57 registered employees. Registered share capital is NOK 500,000, divided into 500 shares. The company's stated purpose is: “Produksjon og utvikling av radiofarmaka til klinisk og forskningsrettet bruk og/eller tilrådighetsstillelse av PET-skannere, samt annen virksomhet i tilknytning til dette.”. The most recent filed accounts, for the 2025 financial year, show NOK 119.9m in revenue and NOK −372,000 in operating profit.
Key figures · 2025
Financial health · 2025
Who owns NORSK MEDISINSK SYKLOTRONSENTER AS?
NORSK MEDISINSK SYKLOTRONSENTER AS has 3 registered shareholders:
- OSLO UNIVERSITETSSYKEHUS HF 70.0%
- UNIVERSITETET I OSLO 20.0%
- AKERSHUS UNIVERSITETSSYKEHUS HF 10.0%
Which companies does NORSK MEDISINSK SYKLOTRONSENTER AS own?
NORSK MEDISINSK SYKLOTRONSENTER AS holds a stake in 1 company:
- ISOTOPES HOLDING AS 93.0%
Frequently asked questions about NORSK MEDISINSK SYKLOTRONSENTER AS
Who owns NORSK MEDISINSK SYKLOTRONSENTER AS?
OSLO UNIVERSITETSSYKEHUS HF is the largest registered owner, with 70.0%.
What is the revenue of NORSK MEDISINSK SYKLOTRONSENTER AS?
NORSK MEDISINSK SYKLOTRONSENTER AS had revenue of NOK 119.9m in 2025.
Who is the general manager of NORSK MEDISINSK SYKLOTRONSENTER AS?
Thor Audun Saga is registered as general manager of NORSK MEDISINSK SYKLOTRONSENTER AS.
Where is NORSK MEDISINSK SYKLOTRONSENTER AS based?
NORSK MEDISINSK SYKLOTRONSENTER AS has its business address in Oslo.
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 03.10.2026.